EXTENDED-RELEASE INJECTABLE GEL FORMULATIONS CONTAINING ANGIOTENSIN-(1-7) OLIGOPEPTIDES OR VARIANTS THEREOF

The present disclosure provides an extended-release gel formulation containing a biocompatible polymer and an angiotensin-(1-7) oligopeptide or a variant thereof. Also provided are methods of treating subjects with vascular dementia, e.g., using the formulations disclosed herein or compositions cont...

Full description

Saved in:
Bibliographic Details
Main Authors HAY, Meredith, RHODES, Christopher, A, OSSANNA, Nina, D'SOUZA, Lawrence, J, PENTICOFF, Katrina
Format Patent
LanguageEnglish
French
German
Published 14.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure provides an extended-release gel formulation containing a biocompatible polymer and an angiotensin-(1-7) oligopeptide or a variant thereof. Also provided are methods of treating subjects with vascular dementia, e.g., using the formulations disclosed herein or compositions containing the same, a subject can be administered the extended-release gel formulation to treat the vascular dementia.
Bibliography:Application Number: EP20220785452